Exact Mass: 493.2675534
Exact Mass Matches: 493.2675534
Found 148 metabolites which its exact mass value is equals to given mass value 493.2675534
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Imatinib
Imatinib is a drug used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It is occasionally referred to as CGP57148B or STI571 (especially in older publications). It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies. It is the first member of a new class of agents that act by inhibiting particular tyrosine kinase enzymes, instead of non-specifically inhibiting rapidly dividing cells. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
4-[[2-Methyl-2-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]propanoyl]amino]adamantane-1-carboxamide
C25H34F3N5O2 (493.26644600000003)
Imatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2742 INTERNAL_ID 2742; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8521 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3633
C28H35N3O5_(1R,5R,7S,12R)-12-Hydroxy-4,4,4,4,12,14-hexamethyl-4H,13H-spiro[9,14-diazatetracyclo[5.5.2.0~1,9~.0~3,7~]tetradecane-5,8-[1,4]dioxepino[2,3-g]indole]-9,13(10H)-dione
C28H35N3O5 (493.25765800000005)
Ala Phe Arg Thr
C22H35N7O6 (493.26486900000003)
Ala Phe Thr Arg
C22H35N7O6 (493.26486900000003)
Ala Arg Phe Thr
C22H35N7O6 (493.26486900000003)
Ala Arg Thr Phe
C22H35N7O6 (493.26486900000003)
Ala Thr Phe Arg
C22H35N7O6 (493.26486900000003)
Ala Thr Arg Phe
C22H35N7O6 (493.26486900000003)
Phe Ala Arg Thr
C22H35N7O6 (493.26486900000003)
Phe Ala Thr Arg
C22H35N7O6 (493.26486900000003)
Phe Arg Ala Thr
C22H35N7O6 (493.26486900000003)
Phe Arg Thr Ala
C22H35N7O6 (493.26486900000003)
Phe Thr Ala Arg
C22H35N7O6 (493.26486900000003)
Phe Thr Arg Ala
C22H35N7O6 (493.26486900000003)
Gly Arg Val Tyr
C22H35N7O6 (493.26486900000003)
Gly Arg Tyr Val
C22H35N7O6 (493.26486900000003)
Gly Val Arg Tyr
C22H35N7O6 (493.26486900000003)
Gly Val Tyr Arg
C22H35N7O6 (493.26486900000003)
Gly Tyr Arg Val
C22H35N7O6 (493.26486900000003)
Gly Tyr Val Arg
C22H35N7O6 (493.26486900000003)
His Ile Pro Gln
C22H35N7O6 (493.26486900000003)
His Ile Gln Pro
C22H35N7O6 (493.26486900000003)
His Leu Pro Gln
C22H35N7O6 (493.26486900000003)
His Leu Gln Pro
C22H35N7O6 (493.26486900000003)
His Pro Ile Gln
C22H35N7O6 (493.26486900000003)
His Pro Leu Gln
C22H35N7O6 (493.26486900000003)
His Pro Gln Ile
C22H35N7O6 (493.26486900000003)
His Pro Gln Leu
C22H35N7O6 (493.26486900000003)
His Gln Ile Pro
C22H35N7O6 (493.26486900000003)
His Gln Leu Pro
C22H35N7O6 (493.26486900000003)
His Gln Pro Ile
C22H35N7O6 (493.26486900000003)
His Gln Pro Leu
C22H35N7O6 (493.26486900000003)
Ile His Pro Gln
C22H35N7O6 (493.26486900000003)
Ile His Gln Pro
C22H35N7O6 (493.26486900000003)
Ile Pro His Gln
C22H35N7O6 (493.26486900000003)
Ile Pro Gln His
C22H35N7O6 (493.26486900000003)
Ile Gln His Pro
C22H35N7O6 (493.26486900000003)
Ile Gln Pro His
C22H35N7O6 (493.26486900000003)
Leu His Pro Gln
C22H35N7O6 (493.26486900000003)
Leu His Gln Pro
C22H35N7O6 (493.26486900000003)
Leu Pro His Gln
C22H35N7O6 (493.26486900000003)
Leu Pro Gln His
C22H35N7O6 (493.26486900000003)
Leu Gln His Pro
C22H35N7O6 (493.26486900000003)
Leu Gln Pro His
C22H35N7O6 (493.26486900000003)
Pro His Ile Gln
C22H35N7O6 (493.26486900000003)
Pro His Leu Gln
C22H35N7O6 (493.26486900000003)
Pro His Gln Ile
C22H35N7O6 (493.26486900000003)
Pro His Gln Leu
C22H35N7O6 (493.26486900000003)
Pro Ile His Gln
C22H35N7O6 (493.26486900000003)
Pro Ile Gln His
C22H35N7O6 (493.26486900000003)
Pro Leu His Gln
C22H35N7O6 (493.26486900000003)
Pro Leu Gln His
C22H35N7O6 (493.26486900000003)
Pro Gln His Ile
C22H35N7O6 (493.26486900000003)
Pro Gln His Leu
C22H35N7O6 (493.26486900000003)
Pro Gln Ile His
C22H35N7O6 (493.26486900000003)
Pro Gln Leu His
C22H35N7O6 (493.26486900000003)
Gln His Ile Pro
C22H35N7O6 (493.26486900000003)
Gln His Leu Pro
C22H35N7O6 (493.26486900000003)
Gln His Pro Ile
C22H35N7O6 (493.26486900000003)
Gln His Pro Leu
C22H35N7O6 (493.26486900000003)
Gln Ile His Pro
C22H35N7O6 (493.26486900000003)
Gln Ile Pro His
C22H35N7O6 (493.26486900000003)
Gln Leu His Pro
C22H35N7O6 (493.26486900000003)
Gln Leu Pro His
C22H35N7O6 (493.26486900000003)
Gln Pro His Ile
C22H35N7O6 (493.26486900000003)
Gln Pro His Leu
C22H35N7O6 (493.26486900000003)
Gln Pro Ile His
C22H35N7O6 (493.26486900000003)
Gln Pro Leu His
C22H35N7O6 (493.26486900000003)
Arg Ala Phe Thr
C22H35N7O6 (493.26486900000003)
Arg Ala Thr Phe
C22H35N7O6 (493.26486900000003)
Arg Phe Ala Thr
C22H35N7O6 (493.26486900000003)
Arg Phe Thr Ala
C22H35N7O6 (493.26486900000003)
Arg Gly Val Tyr
C22H35N7O6 (493.26486900000003)
Arg Gly Tyr Val
C22H35N7O6 (493.26486900000003)
Arg Thr Ala Phe
C22H35N7O6 (493.26486900000003)
Arg Thr Phe Ala
C22H35N7O6 (493.26486900000003)
Arg Val Gly Tyr
C22H35N7O6 (493.26486900000003)
Arg Val Tyr Gly
C22H35N7O6 (493.26486900000003)
Arg Tyr Gly Val
C22H35N7O6 (493.26486900000003)
Arg Tyr Val Gly
C22H35N7O6 (493.26486900000003)
Thr Ala Phe Arg
C22H35N7O6 (493.26486900000003)
Thr Ala Arg Phe
C22H35N7O6 (493.26486900000003)
Thr Phe Ala Arg
C22H35N7O6 (493.26486900000003)
Thr Phe Arg Ala
C22H35N7O6 (493.26486900000003)
Thr Arg Ala Phe
C22H35N7O6 (493.26486900000003)
Thr Arg Phe Ala
C22H35N7O6 (493.26486900000003)
Val Gly Arg Tyr
C22H35N7O6 (493.26486900000003)
Val Gly Tyr Arg
C22H35N7O6 (493.26486900000003)
Val Arg Gly Tyr
C22H35N7O6 (493.26486900000003)
Val Arg Tyr Gly
C22H35N7O6 (493.26486900000003)
Val Tyr Gly Arg
C22H35N7O6 (493.26486900000003)
Val Tyr Arg Gly
C22H35N7O6 (493.26486900000003)
Tyr Gly Arg Val
C22H35N7O6 (493.26486900000003)
Tyr Gly Val Arg
C22H35N7O6 (493.26486900000003)
Tyr Arg Gly Val
C22H35N7O6 (493.26486900000003)
Tyr Arg Val Gly
C22H35N7O6 (493.26486900000003)
Tyr Val Gly Arg
C22H35N7O6 (493.26486900000003)
Tyr Val Arg Gly
C22H35N7O6 (493.26486900000003)
(1R,9S,10S,11S)-12-[2-(dimethylamino)acetyl]-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
C27H35N5O4 (493.26889100000005)
(2R,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C29H36FN3O3 (493.27405580000004)
N-[(5R,6R,9S)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H35N3O5 (493.25765800000005)
N-[(5R,6S,9R)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H35N3O5 (493.25765800000005)
methyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C28H35N3O5 (493.25765800000005)
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
C28H35N3O5 (493.25765800000005)
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
C28H35N3O5 (493.25765800000005)
methyl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C28H35N3O5 (493.25765800000005)
1-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C25H39N3O5S (493.26102840000004)
N-[(5R,6R,9R)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H35N3O5 (493.25765800000005)
N-[(5S,6S,9S)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H35N3O5 (493.25765800000005)
N-[(5S,6S,9R)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H35N3O5 (493.25765800000005)
N-[(5S,6R,9S)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H35N3O5 (493.25765800000005)
methyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C28H35N3O5 (493.25765800000005)
methyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C28H35N3O5 (493.25765800000005)
methyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C28H35N3O5 (493.25765800000005)
1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
C28H35N3O5 (493.25765800000005)
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
C28H35N3O5 (493.25765800000005)
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
C28H35N3O5 (493.25765800000005)
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
C28H35N3O5 (493.25765800000005)
(1S,9R,10R,11R)-12-[2-(dimethylamino)acetyl]-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
C27H35N5O4 (493.26889100000005)
methyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C28H35N3O5 (493.25765800000005)
methyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C28H35N3O5 (493.25765800000005)
(1S,6R,7R,8R)-6-Hydroxy-4,4,6,10,10,13-hexamethylspiro[10H-[1,4]dioxepino[2,3-g]indole-8,11-3,13-diazatetracyclo[5.5.2.01,9.03,7]tetradecane]-9,14-dione
C28H35N3O5 (493.25765800000005)